CONMED Corporation (CNMD) DCF Valuation

CONMED Corporation (CNMD) DCF Valuation

US | Healthcare | Medical - Devices | NYSE
CONMED Corporation (CNMD) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

CONMED Corporation (CNMD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify CONMED Corporation (CNMD) valuation with this customizable DCF Calculator! Featuring real CONMED Corporation (CNMD) financials and adjustable forecast inputs, you can test scenarios and uncover CONMED Corporation (CNMD) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 955.1 862.5 1,010.6 1,045.5 1,244.7 1,338.1 1,438.4 1,546.2 1,662.1 1,786.8
Revenue Growth, % 0 -9.7 17.18 3.45 19.06 7.5 7.5 7.5 7.5 7.5
EBITDA 124.9 113.6 158.4 7.8 192.5 155.6 167.2 179.8 193.2 207.7
EBITDA, % 13.08 13.17 15.67 0.74588 15.46 11.63 11.63 11.63 11.63 11.63
Depreciation 51.0 52.2 49.8 49.8 51.4 67.5 72.5 78.0 83.8 90.1
Depreciation, % 5.34 6.06 4.93 4.76 4.13 5.04 5.04 5.04 5.04 5.04
EBIT 73.9 61.3 108.6 -42.0 141.1 88.1 94.7 101.8 109.4 117.6
EBIT, % 7.74 7.11 10.74 -4.01 11.33 6.58 6.58 6.58 6.58 6.58
Total Cash 25.9 27.4 20.8 28.9 24.3 33.9 36.4 39.2 42.1 45.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 189.1 177.2 183.9 191.3 242.3
Account Receivables, % 19.8 20.54 18.19 18.3 19.46
Inventories 164.6 194.9 231.6 332.3 318.3 321.4 345.5 371.4 399.3 429.2
Inventories, % 17.24 22.59 22.92 31.79 25.57 24.02 24.02 24.02 24.02 24.02
Accounts Payable 56.0 53.3 58.2 73.4 88.2 85.4 91.8 98.7 106.1 114.0
Accounts Payable, % 5.86 6.18 5.76 7.02 7.09 6.38 6.38 6.38 6.38 6.38
Capital Expenditure -20.1 -13.0 -14.9 -21.8 -19.0 -23.3 -25.0 -26.9 -28.9 -31.1
Capital Expenditure, % -2.1 -1.51 -1.47 -2.08 -1.53 -1.74 -1.74 -1.74 -1.74 -1.74
Tax Rate, % 20.25 20.25 20.25 20.25 20.25 20.25 20.25 20.25 20.25 20.25
EBITAT 67.8 364.2 92.9 -47.7 112.5 80.5 86.5 93.0 100.0 107.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -199.1 382.4 89.2 -112.7 122.8 103.3 97.0 104.3 112.1 120.5
WACC, % 9.11 9.22 9.02 9.22 8.95 9.1 9.1 9.1 9.1 9.1
PV UFCF
SUM PV UFCF 413.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 123
Terminal Value 1,731
Present Terminal Value 1,119
Enterprise Value 1,533
Net Debt 967
Equity Value 566
Diluted Shares Outstanding, MM 32
Equity Value Per Share 17.95

What You Will Get

  • Real CONMED Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for CONMED Corporation (CNMD).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit your analysis.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on CONMED's fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections specific to CONMED Corporation (CNMD).
  • Time-Saving and Accurate: Skip building models from scratch while ensuring precision and flexibility in your assessments.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and capital expenditures for CONMED Corporation (CNMD).
  • Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other key financial metrics.
  • High-Precision Accuracy: Utilizes CONMED's actual financial data to ensure realistic valuation results.
  • Seamless Scenario Analysis: Easily evaluate various assumptions and compare different outcomes.
  • Efficiency Booster: Avoid the complexities of building valuation models from the ground up.

How It Works

  • Download: Obtain the pre-formatted Excel file containing CONMED Corporation's (CNMD) financial data.
  • Customize: Modify projections such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation findings to inform your investment choices.

Why Choose This Calculator for CONMED Corporation (CNMD)?

  • Accuracy: Up-to-date CONMED financials guarantee precise data.
  • Flexibility: Tailored for users to easily adjust and experiment with inputs.
  • Time-Saving: Avoid the complexity of creating a DCF model from the ground up.
  • Professional-Grade: Crafted with CFO-level detail and functionality in mind.
  • User-Friendly: Intuitive interface, suitable for users without extensive financial modeling skills.

Who Should Use This Product?

  • Healthcare Students: Understand the financial aspects of medical technology companies and apply valuation methods using real data.
  • Researchers: Integrate advanced financial models into studies related to the healthcare sector.
  • Investors: Validate your investment strategies and evaluate the financial performance of CONMED Corporation (CNMD).
  • Financial Analysts: Enhance your analysis with a customizable DCF model tailored for healthcare companies.
  • Medical Device Entrepreneurs: Learn from the valuation practices of established firms like CONMED Corporation (CNMD).

What the Template Contains

  • Pre-Filled DCF Model: CONMED Corporation’s (CNMD) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate CONMED Corporation’s (CNMD) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.